Fetal stem cell transplantation and gene therapy
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 58, 142-153
Abstract
No abstract availableKeywords
Funding Information
- European Commission
This publication has 41 references indexed in Scilit:
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical TrialsPLOS ONE, 2012
- Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanismsBlood, 2012
- The MSC: An Injury DrugstoreCell Stem Cell, 2011
- Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue propertiesBlood, 2011
- In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfectaBlood, 2009
- Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture HealingStem Cells, 2009
- The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseasesBlood, 2008
- Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta miceBlood, 2008
- Distribution of Single-Cell Expanded Marrow Derived Progenitors in a Developing Mouse Model of Osteogenesis Imperfecta Following Systemic TransplantationStem Cells, 2007
- Immunologic properties of human fetal mesenchymal stem cellsAmerican Journal of Obstetrics and Gynecology, 2004